Desteklenen Projeler
3
-
2015 - Devam Ediyor A 12-week treatment, multi-center, randomized, double-blind, double-dummy, parallel group study to assess the efficacy and safety of switching from salmeterol/fluticasone to QVA149 (indacaterol maleate/glycopyrronium bromide) in symptomatic COPD patients
-
2015 - Devam Ediyor CAPTURE-PH TEDAVİSİNDE ADEMPASA GEÇİŞ YAPILAN PAH VEYA OPERE EDİLEMEYEN İNATÇI TEKRARLAYAN KTEPH HASTALARININ RETROSPEKTİF KAYIT İNCELEMESİ
-
2014 - 2015 A clinical study to compare the effect of fluticasone/vilanterol inhalation powder 100/25 mcg with placebo on survival in subjects with moderate COPD and a history of or at incrased risk for cardiovascular disease
